e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Post-transplant complications: from pathogenesis to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung transplantation in systemic sclerosis: Experience in a spanish center
M. G. Silveira, A. Fernández Codina, C. Berastegui García, V. Monforte Ruiz, V. Fonollosa Pla, C. Pilar Simeon, A. Román Broto (Barcelona, Spain)
Source:
International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Session:
Post-transplant complications: from pathogenesis to treatment
Session type:
Poster Discussion
Number:
3321
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. G. Silveira, A. Fernández Codina, C. Berastegui García, V. Monforte Ruiz, V. Fonollosa Pla, C. Pilar Simeon, A. Román Broto (Barcelona, Spain). Lung transplantation in systemic sclerosis: Experience in a spanish center. Eur Respir J 2014; 44: Suppl. 58, 3321
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Evolution of an interstitial lung disease MDT: 5.5 years of data
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012
The effect of pirfenidone with patients with idiopathic pulmonary fibrosis in one university hospital
Source: International Congress 2014 – ILDs 4
Year: 2014
Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Proportion of idiopathic pulmonary fibrosis among interstitial lung disease in a tertiary care center and its response to treatment
Source: International Congress 2014 – ILDs 5
Year: 2014
Pulmonary function changes during treatment with rituximab in patients with rheumatoid arthritis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Pulmonary interstitial glycogenosis: Diagnosis and follow-up
Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Year: 2016
Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
Late-onset non-infectious pulmonary complications after allogenic-stem cell transplant (LONIPC). Results of treatment strategy with multidisciplinary cooperation
Source: International Congress 2014 – ILDs 3
Year: 2014
Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Cystic lung disease with pulmonary amyloidosis: Analysis of 21 patients
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Lung transplantation in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016
Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept